Rachel Burgoon

Rachel Burgoon

Auto-generated profile, based on publicly available information

Rachel Burgoon

College of Pharmacy, Medical University of South Carolina, Charleston, SC

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2022 in American Journal of Infection Control
Verified
Journal Article
Closed access
RBRachel Burgoon
Rachel Burgoon
EWErin Weeda
Erin Weeda
KHKrutika Mediwala Hornback
Krutika Mediwala Hornback
BRBrian R. Raux
Brian R. Raux

26 November 2025 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
SBSamantha Brace
Samantha Brace
GAGustavo Rey Alvira-Arill
Gustavo Rey Alvira-Arill
AHAaron Hamby
Aaron Hamby
RBRachel Burgoon
Rachel Burgoon
ZGZachary P Gruss
Zachary P Gruss
KHKrutika Mediwala Hornback
Krutika Mediwala Hornback
Background: Antimicrobial stewardship programs (ASPs) aim to optimize antimicrobial use through coordinated interventions that improve patient outcomes and reduce adverse events. While guidance exists from organizations including the Centers for Disease Control and Prevention and the Infectious Diseases Society of America, recommendations on effort allocation, working hours, and initiatives remain unclear. Methods: This cross-sectional survey assessed the institutional structure, effort allocation, initiatives, and on-call participation of adult ASPs in the United States from September to October 2024. The survey was distributed via email to several ASP-related listservs. Respondents indicating on-call participation were also inquired about working hours, initiatives performed, participants, and compensation. Results: Of 69 responses, most were from academic medical centers (59%) or community hospitals (35%), with 65% covering >500 beds. ASPs were often system-wide (78%) and primarily funded by their respective departments of pharmacy (87%). Common initiatives performed by all ASPs include answering ASP/infectious diseases questions, therapy de-escalation, and prospective audit and feedback. Twenty-four (69%) respondents indicated having an on-call model, with said programs reporting higher median inpatient full-time equivalents (FTEs) for physicians (0.5 vs 0.25) and pharmacists (2.9 vs 1.45) than those without. Commonly performed after-hours initiatives include preauthorization and answering microbiology inquiries. On-call coverage was generally performed during weekend daytimes and holidays, most often by pharmacists. Conclusions: This survey highlights differences in structure, effort allocation, and initiatives of ASPs based on on-call participation. Institutions participating in on-call reported higher FTE assignments for physicians and pharmacists and were more likely to perform time-sensitive initiatives.

11 July 2023 in Antimicrobial Stewardship & Healthcare Epidemiology
Verified
Journal Article
Open access
PDF file
RBRachel Burgoon
Rachel Burgoon
AHAaron Hamby
Aaron Hamby
EWErin Weeda
Erin Weeda
BRBrian R. Raux
Brian R. Raux
KHKrutika Mediwala Hornback
Krutika Mediwala Hornback
Background: With increases in antimicrobial resistance, it is crucial that patients receive appropriate antimicrobial therapy in a timely manner. Advancements in rapid diagnostics offer the ability to identify resistant organisms quickly. However, this technology is not always accessible and relies on correct specimen collection. While awaiting new microbiology methods, it may be beneficial to identify risk factors associated with common types of resistance. Specifically, extended-spectrum β-lactamase-producing Enterobacterales (ESBLE) are a rising threat globally. Objective: The primary objective of this retrospective case–control analysis was to identify factors associated with non-urinary ESBLE versus non-ESBLE infections. Design/Methods: Patient cultures were randomly selected based on type of culture (blood, bacterial, or exudate) and organism (E. coli, K. pneumoniae, or K. oxytoca) to provide a 1:1 ratio of ESBLE to non-ESBLE infections. Baseline demographics and potential risk factors (malignancy, cirrhosis, acute kidney injury (AKI), and diabetes) were collected for each patient encounter. Results: In the univariate analysis, risk factors that achieved a significant difference included cirrhosis, AKI, presence of urinary catheter, presence of center venous catheter, history of an ESBLE infection, hospital-acquired infection, and recent fluoroquinolone, cephalosporin, or beta-lactam use. The multivariate analysis showed that four factors were independently associated with an ESBLE infection: cirrhosis, urinary catheter, central venous catheter, and history of ESBLE. Having a history of an ESBLE had the highest adjusted odds ratio (aOR 12.49; 95% CI 4.71–33.15, P < .001) of the four factors. Conclusions: These results demonstrate that there may be benefit in incorporating select risk factors into clinical decision support tools to identify patients at highest risk of ESBLE infection.

17 June 2026 in Clinical Transplantation
Verified
Journal Article
Open access
OFOlubusola Fowowe
Olubusola Fowowe
TMTaylor Morrisette
Taylor Morrisette
AHAaron Hamby
Aaron Hamby
KHKrutika Mediwala Hornback
Krutika Mediwala Hornback
KCKelsey Coffman
Kelsey Coffman
RBRachel Burgoon
Rachel Burgoon
Background: Transitioning from intravenous (IV) to oral antibiotics upon clinical stability in gram‐negative rod (GNR) bloodstream infections (BSI) in immunocompetent patients is effective, with comparable clinical success rates as IV therapy. Studies have historically excluded solid organ transplant (SOT) recipients. This study aims to describe the clinical outcomes of SOT patients who transitioned to oral therapy to manage GNR BSIs. Methods: This retrospective observational cohort was conducted at the Medical University of South Carolina Health between January 2018 and August 2023. SOT recipients 18 years or older with a positive monomicrobial GNR blood culture and a susceptible oral agent were included. The primary outcome was composite clinical success, encompassing the absence of 30‐day mortality, microbiology recurrence, or worsening symptoms without therapy modification. Results: Two hundred and one patients were screened, with 60 meeting the criteria for analysis. The median age was 58 (IQR 50–67) years, 56.7% were male, and 70% had a kidney transplant. The most common causative pathogen was Escherichia coli (58.3%), and the most frequently used oral agents were fluoroquinolones (90.0%). The primary outcome of clinical success was achieved in 90% of patients. The median duration of total therapy was 14 (IQR 13‐14) days, which included 4 (IQR 3‐5) days of IV therapy and 10 (IQR 8‐11) days of oral therapy. Conclusion: This study outlines our institutional experience with transitioning to oral therapy to manage gram‐negative BSI in SOT recipients, demonstrating high clinical success rates. Larger prospective studies in this population are necessary to substantiate and validate our findings.

10 January 2025 in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Verified
Journal Article
Closed access
JJJordan Jones
Jordan Jones
TMTaylor Morrisette
Taylor Morrisette
AHAaron Hamby
Aaron Hamby
KHKrutika Mediwala Hornback
Krutika Mediwala Hornback
RBRachel Burgoon
Rachel Burgoon

10 June 2026 in Antimicrobial Stewardship & Healthcare Epidemiology
Verified
Journal Article
Open access
PDF file
GAGustavo Rey Alvira-Arill
Gustavo Rey Alvira-Arill
SBSamantha Brace
Samantha Brace
TMTaylor Morrisette
Taylor Morrisette
STStephen Andrew Thacker
Stephen Andrew Thacker
AHAaron Hamby
Aaron Hamby
KHKrutika Mediwala Hornback
Krutika Mediwala Hornback
Background: Antimicrobial stewardship programs (ASPs) promote optimal antimicrobial use in pediatrics; however, data describing structure, personnel effort allocation, and activity distribution across regular and after-hours workflows remain limited. Methods: We conducted a cross-sectional survey of pediatric ASPs across the U.S. from September to October 2024 using ASP/ID-related listservs. Respondents reported institutional structure, personnel effort allocation, initiatives, and participation in an after-hours ASP on-call model, with additional details from programs reporting on-call participation. Results: Twenty-two pediatric ASP responses were included, most from academic medical centers (81.8%) and programs covering 101–250 beds (41%). Median physician full-time equivalents (FTEs) increased with institutional size, ranging from 0.1 for institutions with < 100 beds to 0.8 for those with >500 beds. Pharmacist FTEs were a median of 1 for institutions with ≤ 500 beds and increased to 2.25 for programs >500 beds. Most programs reported to Quality and Safety (45%) or discipline-specific departments (41%), with funding primarily attributed to Pharmacy (73%). During regular working hours, nearly all programs performed prospective audit and feedback (100%), responded to ASP-related inquiries (95.5%), and facilitated antimicrobial de-escalation (90.9%). Six programs (27.4%) reported participation in an ASP on-call model, most commonly providing remote coverage during evenings, weekends, and holidays. After-hours activities were largely limited to time-sensitive interventions, including preauthorization and responding to inquiries. Conclusions: Pediatric ASPs demonstrate variability in structure, personnel effort allocation, and stewardship activities. ASP on-call coverage remains uncommon and is typically focused on time-sensitive interventions, reflecting targeted deployment of stewardship resources outside regular working hours.